FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Antengene's Free Cash Flow for the
six
months ended in Dec. 2025 was €-9.60 Mil. Antengene's Revenue for the
six
months ended in Dec. 2025 was €6.32 Mil. Therefore, Antengene's FCF Margin % for the quarter that ended in Dec. 2025 was -151.85%.
The historical rank and industry rank for Antengene's FCF Margin % or its related term are showing as below:
FRA:722'
s FCF Margin % Range Over the Past 10 Years
Min: -2182.69 Med: -419.37 Max: -169.77
Current: -169.77
During the past 8 years, the highest FCF Margin % of Antengene was -169.77%. The lowest was -2182.69%. And the median was -419.37%.
FRA:722's FCF Margin % is ranked worse than 58.92% of 959
companies
in the Biotechnology industry
Industry Median: -84.65
vs FRA:722: -169.77
Antengene FCF Margin % Related Terms
Antengene FCF Margin % Historical Data
* Premium members only.
The historical data trend for Antengene's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:722 vs VRTX, REGN, ALNY: FCF Margin % Comparison
For the Biotechnology subindustry, Antengene's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Antengene FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Antengene's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Antengene's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Antengene (FRA:722) has a FCF Margin % of -151.85% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Antengene and its competitors. According to the industry distribution chart, Antengene ranks #565 out of 959 companies in the Biotechnology industry, placing it in the top 58.9%.
Is Antengene's FCF Margin % too high?
Antengene's current FCF Margin % is -151.85%. Based on the distribution chart, Antengene ranks #565 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Antengene has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Antengene's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Antengene ranks #565 out of 959 companies for FCF Margin %. This places Antengene in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Antengene and its competitors. Antengene's current FCF Margin % is -151.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Antengene stock overvalued right now?
Antengene (FRA:722) has a current FCF Margin % of -151.85%. The stock's GF Value™ is €0.16, compared to a current price of €0.37 — trading 132.5% above its estimated fair value. The current FCF Margin % is -151.85%. Antengene's overall GF Score™ is 39/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Antengene (FRA:722), the current FCF Margin % is -151.85% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Antengene (FRA:722) Overvalued in 2026?
Based on GuruFocus' analysis, Antengene stock appears to be overvalued.
The current stock price of €0.37 is trading 132.5% above its estimated GF Value™ of €0.16.
Key valuation signals for FRA:722:
FCF Margin %: -151.85%
GF Value™: €0.16 vs. price of €0.37 (132.5% above fair value)
No single metric tells the full story. See the FRA:722 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically, it operates in the Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.
39GF Score
Get the complete analysis for FRA:722
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:722 has been successfully added to your 
